JAZZ

2 Biotech Stocks to Buy After Earnings

Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy. More

10 Stocks with 5-Year Returns of 1,500%-Plus

The S&P has roughly doubled in the past five years, but these 10 stocks blow that performance out of the water, with gains of 1,500% or more. More

Why I Believe Markets Are Rigged

Can we learn to thrive in the HFT/algo world of high speed trading? Here are some tips and ideas on how to copy in a fast moving market More

Concert Pharmaceuticals Among This Week’s New Stocks to Watch

Concert Pharmaceuticals and a pair of other biotechs will be among this week's six new stocks to watch. More

Biotech IPOs Lead the Charge of New Stocks This Week

Biotech IPOs have been big hits this year, so it's no surprise that biotech companies lead our list of upcoming IPOs and new stocks to watch for this week. More

Say Yes to Drugs with a Jazz Pharmaceuticals Credit Spread (JAZZ)

Two of Jazz Pharmaceuticals' drugs are showing record growth, and the stock just keeps making new highs. Can it last? More

America’s 10 Fastest Growing Companies

These are the 10 fastest-growing companies in the world according to Fortune. More

Recent Articles